129 related articles for article (PubMed ID: 6252641)
1. A comparison of oestrogen-progestogen with clonidine in the climacteric syndrome.
Sonnendecker EW; Polakow ES
S Afr Med J; 1980 Nov; 58(19):753-6. PubMed ID: 6252641
[TBL] [Abstract][Full Text] [Related]
2. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women.
Gerdes LC; Sonnendecker EW; Polakow ES
Am J Obstet Gynecol; 1982 Jan; 142(1):98-104. PubMed ID: 6275706
[TBL] [Abstract][Full Text] [Related]
3. Effects of conjugated equine oestrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices.
Sonnendecker EW; Polakow ES
S Afr Med J; 1990 Mar; 77(6):281-5. PubMed ID: 2156343
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of the climacteric syndrome. Controlled study of a combination of low-dose clonidine and low-dose conjugated estrogens].
Schindler AE; Heners D; Pater T; Wendel U; Donath EM
Fortschr Med; 1984 Dec; 102(47-48):1213-6. PubMed ID: 6097521
[No Abstract] [Full Text] [Related]
5. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women.
Sonnendecker EW; Polakow ES; Benadé AJ; Simchowitz E
Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1128-34. PubMed ID: 2543223
[TBL] [Abstract][Full Text] [Related]
6. Sonographic changes in the endometrium of climacteric women during hormonal treatment.
Schurz B; Metka M; Heytmanek G; Wimmer-Greinecker G; Reinold E
Maturitas; 1988 Mar; 9(4):367-74. PubMed ID: 2837621
[TBL] [Abstract][Full Text] [Related]
7. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
[TBL] [Abstract][Full Text] [Related]
8. The role of oestrogen replacement in the climacteric syndrome.
Strickler RC; Borth R; Cecutti A; Cookson BA; Harper JA; Potvin R; Riffel P; Sorbara VJ; Woolever CA
Psychol Med; 1977 Nov; 7(4):631-9. PubMed ID: 201958
[TBL] [Abstract][Full Text] [Related]
9. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
Cieraad D; Conradt C; Jesinger D; Bakowski M
Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
[TBL] [Abstract][Full Text] [Related]
10. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.
Wesel S; Bourguignon RP; Bosuma WB
Curr Med Res Opin; 1984; 8(10):696-700. PubMed ID: 6327190
[TBL] [Abstract][Full Text] [Related]
11. The climacteric syndrome: an estrogen replacement dilemma.
Strickler RC; Borth R; Woodlever CA
Can Med Assoc J; 1977 Mar; 116(6):586-7. PubMed ID: 204404
[No Abstract] [Full Text] [Related]
12. Effect of conjugated oestrogen therapy on circulating luteinising hormone in oophorectomised women.
Utian WH; Vinik AI; Bearwood CJ; Beumont PJ
S Afr Med J; 1975 May; 49(20):821-2. PubMed ID: 168645
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with transdermal estradiol in the treatment of the climacteric.
Utian WH
Minerva Endocrinol; 1989; 14(1):45-8. PubMed ID: 2543895
[TBL] [Abstract][Full Text] [Related]
14. [Postmenopausal hormone therapy after WHI and HERS].
Birkhäuser M; de Geyter C; Keller PJ; Luzuy F
Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):244-8. PubMed ID: 15459524
[No Abstract] [Full Text] [Related]
15. A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms.
Place VA; Powers M; Darley PE; Schenkel L; Good WR
Am J Obstet Gynecol; 1985 Aug; 152(8):1092-9. PubMed ID: 2992278
[TBL] [Abstract][Full Text] [Related]
16. Psycho-endocrine differences and correlations in symptomatic and asymptomatic climacteric women - the possible role of prolactin.
Sonnendecker EW; Polakow ES; Gerdes L
S Afr Med J; 1981 Oct; 60(17):661-5. PubMed ID: 6272429
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen on the growth hormone response to the alpha-adrenergic agonist clonidine in women with menopausal flushing.
Tulandi T; Lal S; Guyda H
J Clin Endocrinol Metab; 1987 Jul; 65(1):6-10. PubMed ID: 2884230
[TBL] [Abstract][Full Text] [Related]
18. Clonidine in the treatment of menopausal symptoms.
Ylikorkala O
Ann Chir Gynaecol Fenn; 1975; 64(4):242-5. PubMed ID: 1103700
[TBL] [Abstract][Full Text] [Related]
19. Clonidine (Dixarit) for menopausal flushing.
Edington RF; Chagnon JP; Steinberg WM
Can Med Assoc J; 1980 Jul; 123(1):23-6. PubMed ID: 6998552
[TBL] [Abstract][Full Text] [Related]
20. Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy.
Prior JC; Nielsen JD; Hitchcock CL; Williams LA; Vigna YM; Dean CB
Clin Sci (Lond); 2007 May; 112(10):517-25. PubMed ID: 17419685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
